Adjunctive Intravitreal Bevacizumab Injection at the End of Sutureless 23 G Vitrectomy for Diabetic Vitreous Hemorrhage
نویسندگان
چکیده
منابع مشابه
Adjunctive Intravitreal Bevacizumab Injection at the End of Sutureless 23 G Vitrectomy for Diabetic Vitreous Hemorrhage
This study aims to evaluate the safety and efficacy of intravitreal bevacizumab (IVB) at the end of vitrectomy in prevention of rebleeding in patients with diabetic vitreous hemorrhage. Methods: This is a retrospective interventional study comprised of 30 eyes from 30 patients who underwent 23 G pars plana vitrectomy for diabetic vitreous hemorrhage (VH). IVB (1.25 mg/0.05 ml) was injected at t...
متن کاملIntravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
PURPOSE To evaluate the effect of intravitreal injection of Avastin, bevacizumab (IVA) on diabetic vitrectomy and on the postoperative course. METHODS Thirty patients undergoing diabetic vitrectomy were distributed to standard vitrectomy (group 1) or vitrectomy with preoperative IVA (group 2). Bevacizumab was injected 5 to 7 days before surgery. Patients of both groups were matched as much as...
متن کاملEffect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
We evaluated the effect of intravitreal bevacizumab (IVB) injection before pars plana vitrectomy (PPV) on intravitreal hemorrhage (VH) during and after vitrectomy for postoperative the first day and the first month in pseudophakic patients with proliferative diabetic retinopathy (PDR). This retrospective study was performed on 44 eyes of 44 patients who underwent vitrectomy for PDR. Patients we...
متن کاملRole of Adjunctive Use of Intravitreal Bevacizumab for Severe Proliferative Diabetic Retinopathy before Vitrectomy
Purpose: To evaluate the safety and efficacy of intravitreal injection of bevacizumab advanced to vitrectomy for severe proliferative diabetic retinopathy. Methods: This is a prospective study in which, Ten eyes of ten patients with an average age 54.1 ±6.5 years (45-64 years old) complaining of severe proliferative diabetic retinopathy were investigated. An intravitreal injection of 1.25mg bev...
متن کاملIntravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
Purpose. To determine the efficacy of intravitreal ranibizumab injection as adjuvant therapy in the treatment of neovascular glaucoma (NVG) accompanied by postvitrectomy diabetic vitreous hemorrhage (PDVH). Methods. Eighteen NVG patients (18 eyes) accompanied by PDVH were enrolled in this prospective, monocenter, 12-month, interventional case series. The consecutive 18 patients with an IOP ≥ 25...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of open Access Ophthalmology
سال: 2016
ISSN: 2474-9249
DOI: 10.15226/2474-9249/1/1/00113